LMU University Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
LMU University Hospital brings 10 presentations to ASH 2026 in New Orleans. Its program centres on CAR T-cell therapy and acute myeloid leukemia. It includes dual-targeting CAR-T cells for AML and risk scores for lymphoma patients before CAR-T.
| Organization | ASH 2026 Attendance |
|---|---|
LMU University Hospital Munich, Germany | |
University hospital of Ludwig Maximilian University in Munich, one of Germany's largest academic medical centres. | Symposium Fri Dec 11 11:00am–2:00pm Realigning Modern Care in MCL: Guidance on the Next Wave of Advances With BTK Inhibitor Options and New Targeted Strategies Mantle cell lymphoma care built on Bruton tyrosine kinase inhibitors up front, with newer kinase and Bcl-2 inhibitors or CAR-T after relapse. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 10:30am–12:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at LMU University Hospital
Tell us what you sell and we’ll find the people at LMU University Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction